Daniel J. Lippis — Corporate Vice President, Japan, Greater China and Asia Pacific at Edwards Lifesciences Corporation

Daniel J. Lippis became corporate vice president, Japan, Greater China and Asia Pacific, in January 2024. Lippis has more than 25 years of sales, marketing, business operations and general management experience in the pharmaceutical and medical technology industries. Lippis joined Edwards in 2010 where he led marketing for the transcatheter heart valve (THV) business and subsequently oversaw the successful launches and therapeutic adoption of TAVR and the SAPIEN valve platforms in the U.S. and globally. Most recently, Lippis served as senior vice president of Europe THV where he led sustained growth of TAVR technology in a mature market, developed a high-touch field organization and championed diversity, inclusion and belonging efforts throughout the region. In 2022, his responsibilities were expanded to include business operations and regulatory affairs for Europe, Middle East, Africa, Canada and Latin America. Before joining Edwards, Lippis held sales and marketing leadership positions of increasing responsibility at Johnson & Johnson companies Biosense Webster Inc. and Cordis Inc. based in the United States, Europe, and Asia Pacific. He received a bachelor’s degree in science from the University of Adelaide with a double major in pharmacology and human physiology, and a post-graduate diploma in marketing from the University of Technology Sydney.